Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02165579 · ClinicalTrials.gov registry record
Osteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 36
- Enrollment target
NCT02165579 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 36 participants.
The verdict
NCT02165579 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The investigator plans a cohort study of 80 subjects admitted to hospital with a diabetic foot infection in order to compare serial bone biopsies (the current "gold standard") and procalcitonin to diagnose and monitor the effectiveness of therapy for osteomyelitis. The investigator will collect specimens as part of an existing trial to evaluate negative pressure wound therapy in diabetic infected wounds. A high proportion of these patients have osteomyelitis and will receive standard therapy including repeat bone biopsy and parenteral antibiotics. The investigator expects repeated measurement of procalcitonin will be highly correlated with repeated bone biopsy after antibiotic treatment has been completed to determine if therapy has been successful or if additional antibiotic therapy is needed.
Interventions
- OTHER 1 cohort, standard care, observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2014-06 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02165579
The ClinicalTrials.gov registry entry for NCT02165579 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 1 cohort, standard care, observational is the first listed.
NCT02165579 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02165579 about?
NCT02165579 is a clinical study titled "Osteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis". The investigator plans a cohort study of 80 subjects admitted to hospital with a diabetic foot infection in order to compare serial bone biopsies (the current "gold standard") and procalcitonin to diagnose and monitor the effectiveness of therapy for osteomyelitis. The investigator will collect spec...
What is the current status of trial NCT02165579?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2014-06. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02165579?
The interventions under investigation include: 1 cohort, standard care, observational (OTHER).
Who is sponsoring clinical trial NCT02165579?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.